Alnylam Pharmaceuticals
ALNY
#573
Rank
C$51.69 B
Marketcap
$400.82
Share price
1.16%
Change (1 day)
66.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $434.65 CAD on 2024-10-16

Lowest end of day price: $5.71 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$29.26 1.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$987.85-0.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$165.51-0.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.18 0.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.45 3.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$151.49 1.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$78.31 3.84%๐Ÿ‡ซ๐Ÿ‡ท France
$25.80-3.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel